Molecular Partners AG (0QXX) Financial Statements
Molecular Partners AG Financial Overview
Molecular Partners AG's market cap is currently $116.68M. The company's EPS TTM is $-1.35; its P/E ratio is -2.14; and it has a dividend yield of 1.44%. Molecular Partners AG is estimated to report earnings on March 5, 2027, and the estimated EPS forecast is $-0.35. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 0.00 | $ 4.97M | $ 7.04M | $ 189.56M | $ 9.33M |
| Gross Profit | $ -2.15M | $ -42.53M | $ -40.81M | $ 138.81M | $ -46.39M |
| Operating Income | $ -55.44M | $ -61.22M | $ -61.11M | $ 116.61M | $ -63.42M |
| EBITDA | $ -53.29M | $ -51.63M | $ -59.52M | $ 119.00M | $ -60.66M |
| Net Income | $ -61.65M | $ -54.04M | $ -61.98M | $ 117.85M | $ -63.78M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 93.06M | $ 149.44M | $ 186.89M | $ 249.14M | $ 132.81M |
| Total Assets | $ 102.11M | $ 158.53M | $ 198.35M | $ 262.26M | $ 172.67M |
| Total Debt | $ 3.64M | $ 2.44M | $ 3.65M | $ 4.85M | $ 6.04M |
| Net Debt | $ -79.01M | $ -61.43M | $ -63.66M | $ -83.10M | $ -65.77M |
| Total Liabilities | $ 21.77M | $ 16.89M | $ 21.92M | $ 27.09M | $ 65.38M |
| Stockholders' Equity | $ 80.33M | $ 141.64M | $ 176.43M | $ 235.17M | $ 107.29M |
| Cash Flow | |||||
| Free Cash Flow | $ -50.24M | $ -59.97M | $ -59.81M | $ 117.15M | $ -92.26M |
| Operating Cash Flow | $ -49.53M | $ -59.25M | $ -59.01M | $ 118.57M | $ -90.95M |
| Investing Cash Flow | $ 70.82M | $ 40.49M | $ 44.64M | $ -101.12M | $ -22.24M |
| Financing Cash Flow | $ -1.15M | $ 14.43M | $ -1.17M | $ -1.57M | $ 50.58M |
Currency in CHF
